Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
915.40    11.20 (1.24%)
Bid:
914.80
Ask:
915.40
Spread: 0.60 (0.066%)
Market Cap: £11.48b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Stabilisation Notice

16 Oct 2024 09:49

RNS Number : 4297I
Morgan Stanley & Co. Int'l plc
16 October 2024
 

16 October 2024

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Informa PLC

Pre-stabilisation Period Announcement

Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Daniel Shane; telephone: +44 20 7677-7070) hereby gives notice, as Coordinating Stabilisation Manager, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 supplementing Regulation (EU) No 596/2014 and/or the UK FCA Stabilisation Binding Technical Standards.

Securities

Issuer:

Informa PLC

Guarantor(s) (if any):

Informa Group Holdings Limited

Aggregate nominal amount:

Tranche 1: To be confirmed

Tranche 2: To be confirmed

Tranche 3: To be confirmed

Description:

Tranche 1: EUR Fixed Rate Guaranteed Notes due 2027

Tranche 2: EUR Fixed Rate Guaranteed Notes due 2030

Tranche 3: EUR Fixed Rate Guaranteed Notes due 2034

Offer price:

Tranche 1: To be confirmed

Tranche 2: To be confirmed

Tranche 3: To be confirmed

 

Stabilisation

Stabilisation Manager(s):

Morgan Stanley & Co. International plc

Banco Santander, S.A.

BNP Paribas

HSBC Bank plc

Stabilisation period expected to start on:

The date of this announcement

Stabilisation period expected to end no later than:

22 November 2024

Existence, maximum size and conditions of use of over-allotment facility:

The Stabilisation Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law

Stabilisation trading venue(s):

Euronext Dublin, Global Exchange Market

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

If and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, the UK before the publication of a prospectus in relation to the securities which has been approved by the competent authority in the UK in accordance with Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation"), this announcement and the offer are only addressed to and directed at persons in the UK who are qualified investors within the meaning of the UK Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in the UK.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAMFBPTMTIBMRI
Date   Source Headline
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
30th May 20237:00 amRNSTransaction in Own Shares
26th May 20234:07 pmRNSDirector Declaration
26th May 20237:00 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
24th May 20236:24 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20235:07 pmRNSHolding(s) in Company
18th May 20232:51 pmRNSDirector Declaration
18th May 20237:00 amRNSAcquisition of Winsight
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20239:57 amRNSHolding(s) in Company
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:00 amRNSTransaction in Own Shares
15th May 20237:00 amRNSTransaction in Own Shares
12th May 20237:00 amRNSTransaction in Own Shares
11th May 20236:25 pmRNSDirector Declaration
11th May 20237:00 amRNSTransaction in Own Shares
10th May 20234:18 pmRNSHolding(s) in Company
10th May 20237:00 amRNSTransaction in Own Shares
9th May 202310:07 amRNSHolding(s) in Company
9th May 20237:00 amRNSTransaction in Own Shares
5th May 20237:00 amRNSTransaction in Own Shares
4th May 20237:00 amRNSTransaction in Own Shares
3rd May 20232:14 pmRNSHolding(s) in Company
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20239:43 amRNSTotal Voting Rights
2nd May 20239:39 amRNSHolding(s) in Company
2nd May 20237:00 amRNSTransaction in Own Shares
28th Apr 20238:59 amRNSAnnual Financial Report & Notice of 2023 AGM
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20239:19 amRNSHolding(s) in Company
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 202310:01 amRNSHolding(s) in Company
19th Apr 20237:00 amRNSTransaction in Own Shares
18th Apr 20231:45 pmRNSTotal Voting Rights
18th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20232:41 pmRNSHolding(s) in Company
14th Apr 202310:50 amRNSHolding(s) in Company
14th Apr 202310:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.